Skip to content
Health News

Oxford-AstraZeneca Covid jab safe, insists Hancock

By health | March 17, 2021
0 Comment

[unable to retrieve full-text content]People should “get the jab”, the health secretary says, after some countries suspend its use.
BBC News – Health

Category: Advertising & Marketing Tags: COVID, Hancock, insists, OxfordAstraZeneca, Safe
Post navigation
← Gundry MD 24 Strain Probiotic Review 2021 – Probiotic For Digestive Support Transparency watchdog criticizes STAT’s non-disclosure on pro-Pharma op-ed →
  • Nourishing from Within: How a Blood Health Diet Can Transform Your Life

    When we think about health, our minds often jump to things like heart health, a strong immune system, or clear skin. But at the core of all these functions is something we often take for granted: our blood. Our blood is the body’s transportation system, carrying oxygen, nutrients, and hormones to every cell and taking… Read More »

  • Green coffee use in bodybuilding

    Purely Inspired Green Coffee – tablets Add review. Marc has been involved in many avenues of the fitness industry. What is it Reviews 9. If you’re already a coffee addict, the benefits of green tea extract and GCE supplements will likely be less effective. If fat loss is your goal, is one extract better than… Read More »

  • The members-only New York Society Library is the city’s best-kept secret

    Shhhhh! The New York Society Library might just be one of the city’s best-kept secrets.  Located in a beautiful townhouse at 53 E. 79th St. (near Madison Ave), the members-only library is New York’s oldest. For an annual fee of $ 270 per person ($ 350 for a family), members can check out books —… Read More »

  • FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers

    FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers Print this page INDIANAPOLIS, May 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Retevmo™ (selpercatinib, 40 mg & 80 mg capsules), the first therapy specifically indicated for the treatment of adult patients with… Read More »

Copyright 2017
Iconic One Theme | Powered by Wordpress